Chiron Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Chiron Capital Management's PFE Position: Q3 2026 in Review
Chiron Capital Management reduced its Pfizer (PFE) stake by 51% in Q3 2026, selling an estimated $906K and leaving 33,164 shares worth $946K. The position accounts for 0.94% of the portfolio, ranked #33.
Chiron Capital Management first reported a position in PFE in Q3 2020 and has held it in 24 quarters since. The position peaked at $5.57M in Q1 2021. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Chiron Capital Management held 33,164 shares of Pfizer worth $946K as of Q3 2026.
- Chiron Capital Management sold 34,050 Pfizer shares in Q3 2026, an estimated $906K.
- Pfizer made up 0.94% of Chiron Capital Management's portfolio in Q3 2026, its #33 holding.
- Chiron Capital Management first reported a position in Pfizer in Q3 2020 and has held it in 24 quarters since.
- Chiron Capital Management's Pfizer position peaked at $5.57M in Q1 2021.
- 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Chiron Capital Management's 13F filing for Q3 2026, filed 15 Oct 2026.